New drugs-reports of new drugs recently approved by the FDA. Abacavir sulfate.

doi:10.1016/s0968-0896(99)00242-4

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

New drugs-reports of new drugs recently approved by the FDA. Abacavir sulfate.

Bioorganic & medicinal chemistry - 1 Dec 1999

Huff J R

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Dideoxynucleosides
Share to Drug Approval
Share to Drug Hypersensitivity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to HIV

Share to Reverse Transcriptase Inhibitors

Share to United States Food and Drug Administration

Source

Open in PubMed

Identifiers

PMID: 10658570
DOI: 10.1016/s0968-0896(99)00242-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New drugs-reports of new drugs recently approved by the FDA. Abacavir sulfate.PMID 10658570Read ↗

New drugs.Semantic proximity Read ↗

No compelling reason to adopt new antivirals whenever it is reasonable to wait.Semantic proximity Read ↗

FDA triple header. Food and Drug Administration.Semantic proximity Read ↗

New antiretroviral drugs part I: PIs.Semantic proximity Read ↗

[Drugs for hepatitis B and C infection].Semantic proximity Read ↗

Clinical update: adverse effects of antiretroviral therapySemantic proximity Read ↗

Anti-HIV agents. Monotherapy studies--points to consider.Semantic proximity Read ↗

A new era of antiretroviral drug toxicity.Semantic proximity Read ↗

[New clinical evidence and drugs].Semantic proximity Read ↗

Management of direct-acting antiviral agent failuresSemantic proximity Read ↗

The medical merry-go-round: drugs for 1998 are new but not novel.Semantic proximity Read ↗

Pharmacogenomics testing for type B adverse drug reactions to anti-infective drugs: the example of hypersensitivity to abacavir.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.